Cargando…
Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
Progress into developing therapeutics for rare diseases can be accelerated for those diseases that can be modeled in genetically tractable organisms. Here we comment on one disease, Duchenne Muscular Dystrophy (DMD), modeled in Drosophila that brought together disparate lines of research toward the...
Autores principales: | Pantoja, Mario, Ruohola-Baker, Hannele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932943/ https://www.ncbi.nlm.nih.gov/pubmed/25002997 http://dx.doi.org/10.4161/rdis.24995 |
Ejemplares similares
-
The immune system in Duchenne muscular dystrophy: Friend or foe
por: Villalta, S Armando, et al.
Publicado: (2015) -
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016) -
Chronic Hypoxia Impairs Muscle Function in the Drosophila Model of Duchenne's Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2010) -
Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
por: Giordani, L, et al.
Publicado: (2014) -
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
por: Nguyen-Tran, Diem-Hang, et al.
Publicado: (2014)